Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: A systematic review protocol

Systematic Reviews

Volumn 1, Issue 1, 2012, Pages

  Young, Matthew M ^a,b   Stevens, Adrienne ^c   Porath Waller, Amy ^a   Pirie, Tyler ^a   Garritty, Chantelle ^c   Skidmore, Becky ^d   Turner, Lucy ^c   Arratoon, Cheryl ^a   Haley, Nancy ^e,f   Leslie, Karen ^g   Reardon, Rhoda ^h   Sproule, Beth ^g   Grimshaw, Jeremy ^c,i   Moher, David ^c,i  

^a Canadian Centre on Substance Use and Addiction   (Canada)

^b CARLETON UNIVERSITY   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d Independent Research and Information Consultant   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h The College of Physicians and Surgeons of Ontario   (Canada)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Brief intervention; Drug use; Psychoactive substance; Referral to treatment; SBIRT; Screening; Substance use; Systematic review

Indexed keywords

3, 4 METHYLENEDIOXYMETHAMPHETAMINE; ACETONE; ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; CAFFEINE; CANNABIS; COCAINE; DEXTROMETHORPHAN; DIAMORPHINE; GASOLINE; ILLICIT DRUG; NICOTINE; OPIATE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; PSYCHOTHERAPY; SCREENING BRIEF INTERVENTION AND REFERRAL TO TREATMENT; SENSITIVITY ANALYSIS; SUBSTANCE ABUSE; SYSTEMATIC REVIEW (TOPIC); ADDICTION; ADOLESCENT; ADULT; CANADA; CHILD; CLINICAL TRIAL (TOPIC); EARLY INTERVENTION; FEMALE; HARM REDUCTION; INTEGRATED HEALTH CARE SYSTEM; INTERVENTION STUDY; LITERATURE; MALE; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT;

ADOLESCENT; ADULT; CANADA; CHILD; CLINICAL TRIALS AS TOPIC; DELIVERY OF HEALTH CARE, INTEGRATED; EARLY MEDICAL INTERVENTION; FEMALE; HARM REDUCTION; HUMANS; INTERVENTION STUDIES; MALE; MASS SCREENING; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 84876187011     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-1-22     Document Type: Article

References (43)

1. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L. Reporting Guidelines for Systematic Review Protocols 2011, Madrid, Spain:In 19th Cochrane Colloquium: October 19-22 2011.
2. Health Canada Canadian Alcohol and Drug Use Monitoring Survey (CADUMS). http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2010/summary-sommaire-eng.php, Health Canada.
3. Rehm J, Baliunas D, Brochu S, Fischer B, Gnam W, Patra J, Popova S, Sarnocinska-Hart A, Taylor B. The costs of substance abuse in Canada 2002 2006, Canadian Centre on Substance Abuse, Ottawa, ON.
4. Degenhardt L, Hall W, Warner-Smith M, Lynskey M. Illicit drug use. Global and regional burden of diseases attributable to selected major risk factors 2004, World Health Organization, Geneva, Ezzati M, Lopez AD, Rogers A, Murray CJL, 1.
5. Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus 2007, 28(3):7-30. 10.1300/J465v28n03_03, 18077300.
6. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Part II. Addiction 1993, 88:791-804.
7. Adamson SJ, Sellman JD. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev 2003, 22(3):309-315. 10.1080/0959523031000154454, 15385225.
8. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005, 6(6):432-442. 10.1111/j.1526-4637.2005.00072.x, 16336480.
9. Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict 1989, 84(3):301-307. 10.1111/j.1360-0443.1989.tb03463.x, 2650770.
10. Carney T, Myers BJ, Louw J. Brief school-based interventions and behavioural outcomes for substance-using adolescents. Cochrane Database Syst Rev 2011, 2:CD008969.
11. Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, Heather N, Saunders J, Burnand B. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007, 2:CD004148.
12. McQueen J, Howe TE, Allan L, Mains D, Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev 2011, 8:CD005191.
13. Levy S, Vaughan BL, Knight JR. Office-based intervention for adolescent substance abuse. Pediatr Clin N Am 2002, 49(2):329-343.
14. Kahan M, Wilson L, Becker L. Effectiveness of physician-based interventions with problem drinkers: a review. Canadian Med Assoc J 1995, 152(6):851-859.
15. Reid MC, Fiellin DA, O'Connor PG. Hazardous and harmful alcohol consumption in primary care. Arch Intern Med 1999, 159(15):1681-1689. 10.1001/archinte.159.15.1681, 10448769.
16. Wilk AI, Jensen NM, Havighurst TC. Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Int Med 1997, 12(5):274-283.
17. Copeland J, Swift W, Roffman R, Stephens R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abus Treat 2001, 21(2):55-64.
18. Humeniuk R, Ali R, Babor T, Souza-Formigoni ML, de Lacerda RB, Ling W, McRee B, Newcombe D, Pal H, Poznyak V, Simon S, Vendetti J. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health care settings in four countries. Addiction 2012, 107(5):957-966. 10.1111/j.1360-0443.2011.03740.x, 22126102.
19. Lang E, Engelander M, Brooke T. Report of an integrated brief intervention with self-defined problem cannabis users. J Subst Abus Treat 2000, 19(2):111-116.
20. Martin G, Copeland J, Swift W. The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users. J Subst Abus Treat 2005, 29(3):207-213.
21. McCambridge J, Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 2004, 99(1):39-52. 10.1111/j.1360-0443.2004.00564.x, 14678061.
22. Martin G, Copeland J. Brief intervention for regular ecstasy (MDMA) user: pilot randomized trial of a Check-Up model. J Subs Use 2010, 15(2):131-142.
23. Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend 2005, 77(1):49-59. 10.1016/j.drugalcdep.2004.07.006, 15607841.
24. Stotts AL, Schmitz JM, Rhoades HM, Grabowski J. Motivational interviewing with cocaine-dependent patients: a pilot study. J Consult Clin Psychol 2001, 69(5):858-862.
25. Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract 1994, 44(386):408-412. 1238990, 8790654.
26. Saitz R, Alford DP, Bernstein J, Cheng DM, Samet J, Palfai T. Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J Addiction Med 2010, 4(3):123-130.
27. Walker DD, Roffman RA, Stephens RS, Wakana K, Berghuis J, Kim W. Motivational enhancement therapy for adolescent marijuana users: a preliminary randomized controlled trial. J Consult Clin Psychol 2006, 74(3):628-632. 2587139, 16822119.
28. McCabe SE, Cranford JA, West BT. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav 2008, 33(10):1297-1305. 10.1016/j.addbeh.2008.06.005, 3163593, 18632211.
29. The Cochrane Collaboration Suggested risk of bias criteria for EPOC reviews http://epocoslo.cochrane.org/sites/epocoslo.cochrane.org/files/uploads/Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews.pdf, The Cochrane Collaboration.
30. Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J. PRESS: Peer Review of Electronic Search Strategies 2008, Canadian Agency for Drugs and Technologies in Health, Ottawa, ON.
31. Canadian Agency for Drugs and Technologies in Health Grey Matters: a practical tool for evidence-based searching. http://cadth.ca/resources/grey-matters, Canadian Agency for Drugs and Technologies in Health.
32. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151(4):264-269. W264.
33. Reeves BC, Deeks JJ, Higgins JPT, Wells GA, Higgins JPT, Altman DG, Sterne JAC, , the Cochrane Non-Randomised Studies Methods Group, the Cochrane Non-Randomised Studies Methods Group Chapter 13.5: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10 2011, The Cochrane Collaboration, Higgins JPT, Green S, http://www.cochrane-handbook.org, the Cochrane Non-Randomised Studies Methods Group, the Cochrane Non-Randomised Studies Methods Group.
34. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10 2011, The Cochrane Collaboration, Higgins JPT, Green S, http://www.cochrane-handbook.org.
35. Killip S, Mahfoud Z, Pearce K. What is an intracluster correlation coefficient? Crucial concepts for primary care researchers. Ann Fam Med 2004, 2(3):204-208. 10.1370/afm.141, 1466680, 15209195.
36. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10 2011, The Cochrane Collaboration, Higgins JPT, Green S.
37. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statis Med 1998, 17(24):2815-2834.
38. Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care 2003, 19(4):613-623.
39. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011, 343:d4002. 10.1136/bmj.d4002, 21784880.
40. Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10 2011, The Cochrane Collaboration, Higgins JPT, Green S, http://www.cochrane-handbook.org.
41. The GRADE Working Group List of GRADE working group publications and grants. http://www.gradeworkinggroup.org/publications/index.htm, The GRADE Working Group.
42. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007, 7:10. 10.1186/1471-2288-7-10, 1810543, 17302989.
43. Garritty C, Ansari M, Yazdi F, Singh K, Galipeau J, Pratt M, Young MM, Skidmore R, Lal A, Daniel R, Moher D, Grimshaw J. Evidence map of systematic reviews to inform the prevention, treatment, and/or harm reduction for illicit drug use. Report submitted to the Institute of Neuroscience, Addiction & Mental Health (INMHA). Canadian Institutes Health Res (CIHR) 2011, www.ohri.ca/ksgroup/publications.asp.